Distinct Dynamics of Migratory Response to PD-1 and CTLA-4 Blockade Reveals New Mechanistic Insights for Potential T-Cell Reinvigoration following Immune Checkpoint Blockade
Fateme Safaeifard(University of Tehran), Curzio Rüegg(University of Fribourg), Sama Goliaei(University of Tehran), Seyed Peyman Shariatpanahi(University of Tehran), David A. Barbie(Dana-Farber Cancer Institute), Amir Reza Aref(Massachusetts General Hospital), Bahram Goliaei(University of Tehran), Jochen H. Lorch(Northwestern University), Mohammad-Hadi Foroughmand-Araabi(Sharif University of Technology), Russell W. Jenkins(Broad Institute)
Cited by 3
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
|Cell|2018|2k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.5k
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766